Lecanemab, also known as Leqembi, has made headlines as the first drug ever approved in the UK by the MHRA that can slow down early-stage Alzheimer’s disease, but it has not been recommended for use in the NHS at this stage. Here is what we know so far.

People living with Alzheimer’s are helping researchers to test a brain stimulation technique that could lead to future treatments. 

A new trial called COBALT is looking for people with dementia with Lewy bodies or Parkinson’s disease dementia to see if using two drugs together could help improve their symptoms.

Getting an early and accurate dementia diagnosis will only become more important as new treatments become available, so research into this area is vital.

Important as they are, drugs and technology aren’t the only ways to make a difference for people living with dementia – could you help?

Hear from volunteers helping to research new technology which could enable people with dementia to remain independent for longer.

With recent hopeful drug findings, Sharon Boulter, Research Participation Officer, looks at taking part in clinical trials.

We need research to change how dementia affects people’s lives, and researchers need volunteers.